Goldman initiated coverage of Doximity with a rating of Neutral and set a new price target of $58.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/2/2025 | $80.00 | Neutral → Buy | BTIG Research |
| 2/7/2025 | $31.00 → $78.00 | Neutral → Overweight | Piper Sandler |
| 2/7/2025 | $60.00 → $90.00 | Market Perform → Outperform | Leerink Partners |
| 12/20/2024 | $55.00 | Equal-Weight | Stephens |
| 12/4/2024 | $55.00 | Neutral | Mizuho |
| 11/15/2024 | $58.00 | Neutral | Goldman |
| 11/14/2024 | $33.00 → $53.00 | Underweight → Equal-Weight | Morgan Stanley |
| 11/13/2024 | $40.00 → $60.00 | Buy → Hold | Canaccord Genuity |